Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Forty-nine men performed progressive submaximal treadmill exercise to determine the cardiopulmonary and subjective response to added resistance to breathing. Twenty subjects (controls), FEV1/FVC% = 79.2 +/- 1.4 (mean +/-
SEM
), were compared with 19 mildly obstructed men (
OB1
), FEV1/FVC% = 66.9 +/- 0.5, and 10 with moderate obstruction (OB2), FEV1/FVC% = 53.7 +/- 1.9. Separate exercise trials were performed with no added resistance (NAR), R1 = 3.5 cm H2O/L/s inspiratory and 1.5 cm H2O/L/s expiratory resistance, and R2 = 5 cm HKO/L/s inspiratory and 1.5 cm H2O/L/s expiratory resistance. Analysis of cardiopulmonary parameters was made at an oxygen consumption rate of VO2 = 1.5 L/min for all 3 obstruction groups at all 3 resistances. With NAR, all 3 groups had similar respiratory rate (RR), tidal volume (VT), minute ventilation (VE), end-tidal PCO2 (PETCO2), respiratory exchange ratio (R), heart rate (HR), and mouth pressure swing (Poral). With both R1 and R2 compared with NAR, control and
OB1
subjects (at VO2 = 1.5 L/min) had reduced RR, VE, and R, and increased VT and Poral (p less than 0.01 for all). Changes with added resistance for OB2 subjects were in the same directions, but were significant only for VE and with R1 for RR. Heart rate did not change; PETCO2 increased in control subjects and with R2 in
OB1
subjects. Separate analysis showed that except for the smaller increase in PETCO2 in OB2 subjects, none of the changes with added resistance in the
OB1
or OB2 groups were different from changes in the control group.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Effects of added resistance to breathing during exercise in obstructive lung disease. 663 85